GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thalys Medical Technology Group Corp (SHSE:603716) » Definitions » 3-Year Revenue Growth Rate

Thalys Medical Technology Group (SHSE:603716) 3-Year Revenue Growth Rate : -10.40% (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Thalys Medical Technology Group 3-Year Revenue Growth Rate?

Thalys Medical Technology Group's Revenue per Share for the three months ended in Mar. 2025 was ¥1.41.

During the past 12 months, Thalys Medical Technology Group's average Revenue per Share Growth Rate was -32.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was -10.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was -0.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 14.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Thalys Medical Technology Group was 38.00% per year. The lowest was -10.40% per year. And the median was 18.00% per year.


Competitive Comparison of Thalys Medical Technology Group's 3-Year Revenue Growth Rate

For the Diagnostics & Research subindustry, Thalys Medical Technology Group's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thalys Medical Technology Group's 3-Year Revenue Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thalys Medical Technology Group's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Thalys Medical Technology Group's 3-Year Revenue Growth Rate falls into.


;
;

Thalys Medical Technology Group 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Thalys Medical Technology Group  (SHSE:603716) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Thalys Medical Technology Group 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Thalys Medical Technology Group's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Thalys Medical Technology Group Business Description

Traded in Other Exchanges
N/A
Address
1310 Jinshan Avenue, Dongxihu District, Hubei Province, Wuhan, CHN, 430040
Thalys Medical Technology Group Corp is engaged in intensive sales business, pure sales, and research and development, production and sales of independent in vitro diagnostic products.
Executives
Wang Jun Ming senior management
Wang Zheng senior management
Wang Wen Bin senior management
Liu Wen Hao Director
Huang Yong Xi senior management
Lei Xian Kun Director
Fan Li Director
Liu Yuan senior management
Wan Li Bo senior management
Wen Wei Director
Chou Jian senior management
Song Yu Director

Thalys Medical Technology Group Headlines

No Headlines